Literature DB >> 8708702

Valproate induced encephalopathy treated with carnitine in an adult.

D Beversdorf, C Allen, R Nordgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8708702      PMCID： PMC1074008          DOI： 10.1136/jnnp.61.2.211

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.

Authors:  T Sugimoto; N Nishida; K Murakami; M Woo; Y Sakane; A Yasuhara; H Shuto; T Hatanaka; Y Kobayashi
Journal:  Jpn J Psychiatry Neurol       Date:  1990-06

2.  Carnitine deficiency associated with anticonvulsant therapy.

Authors:  S Rodriguez-Segade; C A de la Peña; J C Tutor; J M Paz; M P Fernandez; I Rozas; R Del Río
Journal:  Clin Chim Acta       Date:  1989-05-15       Impact factor: 3.786

3.  Valproate-induced coma with ketosis and carnitine insufficiency.

Authors:  W J Triggs; T P Bohan; S N Lin; L J Willmore
Journal:  Arch Neurol       Date:  1990-10
  3 in total
  4 in total

1.  Sodium valproate-induced myopathy in a child.

Authors:  Riaz Ahmed
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

2.  Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.

Authors:  Ahmed Al-sharefi; Rudy Bilous
Journal:  BMJ Case Rep       Date:  2015-09-02

3.  Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update.

Authors:  S Vivekanandan; S Dinesh Nayak
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

4.  Valproate-induced encephalopathy with predominant pancerebellar syndrome.

Authors:  Rajesh Verma; Prakash Kori
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.